secwatch.observer — SEC 8-K summary
======================================

Issuer:     VIVEVE MEDICAL, INC. (—)
CIK:        0000879682
Form:       8-K
Filed at:   2022-11-23T23:59:59+00:00
Accession:  0001437749-22-028025
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Viveve Medical receives Nasdaq deficiency notice for stockholders' equity below $2.5M
--------------------------------------------------------------------------------

- Reported stockholders' equity of $1,184,000 as of Sept 30, 2022, below Nasdaq's $2,500,000 minimum.
- Nasdaq gave company 45 days (until Jan 3, 2023) to submit a plan to regain compliance.
- If plan accepted, company has up to 180 days from Nov 18, 2022 to evidence compliance.
- Company also previously disclosed non-compliance with minimum bid price rule ($1.00/share) on June 3, 2022.
- No assurance of regaining compliance; failure could lead to delisting and hearing rights.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/879682/000143774922028025/0001437749-22-028025-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/879682/000143774922028025/vive20221122_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-028025

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer